Thursday, September 17, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Researchmots-cpcosmitochondrial peptides

Correction issued on MOTS-c levels study in PCOS patients

Scientific Reports publishes a correction to research linking reduced MOTS-c to mitochondrial dysfunction in polycystic ovary syndrome.

PR
By Priya Raman · Science Reporter
Sep 8 20:00 ETSource: Scientific reports

The wire

  1. 01A correction was published for a study reporting reduced serum and skeletal muscle MOTS-c in women with PCOS.
  2. 02MOTS-c is a mitochondrial-derived peptide of growing interest in metabolic disease.
  3. 03The nature and extent of the correction are not specified in the source.

From the source

Correction: Reduced serum and skeletal muscle MOTS c levels in women with polycystic ovary syndrome are associated with mitochondrial dysfunction

Scientific reports · 2026 Sep 9 · Kutuk IS, Akin S, Demirel H et al.

Read at pubmed.ncbi.nlm.nih.gov
Source URL https://pubmed.ncbi.nlm.nih.gov/42716952/